These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

105 related articles for article (PubMed ID: 1651809)

  • 61. Oxidative metabolism of zolpidem by human liver cytochrome P450S.
    Pichard L; Gillet G; Bonfils C; Domergue J; Thénot JP; Maurel P
    Drug Metab Dispos; 1995 Nov; 23(11):1253-62. PubMed ID: 8591727
    [TBL] [Abstract][Full Text] [Related]  

  • 62. Cytochrome P-450s as toxicogenic catalysts: the influence of dehydroepiandrosterone.
    Estabrook RW; Milewich L; Prough RA
    Princess Takamatsu Symp; 1990; 21():33-44. PubMed ID: 2151997
    [TBL] [Abstract][Full Text] [Related]  

  • 63. Metabolic activation of 4-ipomeanol by avian tissue microsomes.
    Buckpitt AR; Boyd MR
    Toxicol Appl Pharmacol; 1982 Aug; 65(1):53-62. PubMed ID: 7147255
    [No Abstract]   [Full Text] [Related]  

  • 64. Azide inhibits human cytochrome P -4502E1, 1A2, and 3A4.
    Salmela KS; Tsyrlov IB; Lieber CS
    Alcohol Clin Exp Res; 2001 Feb; 25(2):253-60. PubMed ID: 11236840
    [TBL] [Abstract][Full Text] [Related]  

  • 65. Characterization of the human cytochrome P450 isozymes responsible for styrene metabolism.
    Nakajima T; Elovaara E; Gonzalez FJ; Gelboin HV; Vainio H; Aoyama T
    IARC Sci Publ; 1993; (127):101-8. PubMed ID: 8070855
    [TBL] [Abstract][Full Text] [Related]  

  • 66. Metabolism of the active metabolite of quetiapine, N-desalkylquetiapine in vitro.
    Bakken GV; Molden E; Knutsen K; Lunder N; Hermann M
    Drug Metab Dispos; 2012 Sep; 40(9):1778-84. PubMed ID: 22688609
    [TBL] [Abstract][Full Text] [Related]  

  • 67. Bioactivation of 4-Ipomeanol by a CYP4B enzyme in bovine lung and inhibition by HET0016.
    Parkinson OT; Kelly EJ; Bezabih E; Whittington D; Rettie AE
    J Vet Pharmacol Ther; 2012 Aug; 35(4):402-5. PubMed ID: 21919916
    [No Abstract]   [Full Text] [Related]  

  • 68. Development of tolerance to the pulmonary toxin, 4-ipomeanol.
    Boyd MR; Burka LT; Wilson BJ; Sastry BV
    Toxicology; 1981; 19(2):85-100. PubMed ID: 6791310
    [No Abstract]   [Full Text] [Related]  

  • 69. 4-Ipomeanol: a novel investigational new drug for lung cancer.
    Christian MC; Wittes RE; Leyland-Jones B; McLemore TL; Smith AC; Grieshaber CK; Chabner BA; Boyd MR
    J Natl Cancer Inst; 1989 Aug; 81(15):1133-43. PubMed ID: 2664191
    [TBL] [Abstract][Full Text] [Related]  

  • 70. Spotlight on CYP4B1.
    Röder A; Hüsken S; Hutter MC; Rettie AE; Hanenberg H; Wiek C; Girhard M
    Int J Mol Sci; 2023 Jan; 24(3):. PubMed ID: 36768362
    [TBL] [Abstract][Full Text] [Related]  

  • 71. Human Family 1-4 cytochrome P450 enzymes involved in the metabolic activation of xenobiotic and physiological chemicals: an update.
    Rendic SP; Guengerich FP
    Arch Toxicol; 2021 Feb; 95(2):395-472. PubMed ID: 33459808
    [TBL] [Abstract][Full Text] [Related]  

  • 72. A history of the roles of cytochrome P450 enzymes in the toxicity of drugs.
    Guengerich FP
    Toxicol Res; 2021 Jan; 37(1):1-23. PubMed ID: 32837681
    [TBL] [Abstract][Full Text] [Related]  

  • 73. Novel advances in biotransformation and bioactivation research-2019 year in review
    Khojasteh SC; Driscoll JP; Jackson KD; Miller GP; Mitra K; Rietjens IMCM; Zhang D
    Drug Metab Rev; 2020 Aug; 52(3):333-365. PubMed ID: 32645275
    [TBL] [Abstract][Full Text] [Related]  

  • 74. Noncovalent interactions dominate dynamic heme distortion in cytochrome P450 4B1.
    Jennings GK; Hsu MH; Shock LS; Johnson EF; Hackett JC
    J Biol Chem; 2018 Jul; 293(29):11433-11446. PubMed ID: 29858244
    [TBL] [Abstract][Full Text] [Related]  

  • 75. Optimized human CYP4B1 in combination with the alkylator prodrug 4-ipomeanol serves as a novel suicide gene system for adoptive T-cell therapies.
    Roellecke K; Virts EL; Einholz R; Edson KZ; Altvater B; Rossig C; von Laer D; Scheckenbach K; Wagenmann M; Reinhardt D; Kramm CM; Rettie AE; Wiek C; Hanenberg H
    Gene Ther; 2016 Jul; 23(7):615-26. PubMed ID: 27092941
    [TBL] [Abstract][Full Text] [Related]  

  • 76. Characterization of an Additional Splice Acceptor Site Introduced into CYP4B1 in Hominoidae during Evolution.
    Schmidt EM; Wiek C; Parkinson OT; Roellecke K; Freund M; Gombert M; Lottmann N; Steward CA; Kramm CM; Yarov-Yarovoy V; Rettie AE; Hanenberg H
    PLoS One; 2015; 10(9):e0137110. PubMed ID: 26355749
    [TBL] [Abstract][Full Text] [Related]  

  • 77. Comparative pathobiology of environmentally induced lung cancers in humans and rodents.
    Pandiri A
    Toxicol Pathol; 2015 Jan; 43(1):107-14. PubMed ID: 25351923
    [TBL] [Abstract][Full Text] [Related]  

  • 78. Identification of amino acid determinants in CYP4B1 for optimal catalytic processing of 4-ipomeanol.
    Wiek C; Schmidt EM; Roellecke K; Freund M; Nakano M; Kelly EJ; Kaisers W; Yarov-Yarovoy V; Kramm CM; Rettie AE; Hanenberg H
    Biochem J; 2015 Jan; 465(1):103-14. PubMed ID: 25247810
    [TBL] [Abstract][Full Text] [Related]  

  • 79. Generation and characterization of a Cyp4b1 null mouse and the role of CYP4B1 in the activation and toxicity of Ipomeanol.
    Parkinson OT; Liggitt HD; Rettie AE; Kelly EJ
    Toxicol Sci; 2013 Aug; 134(2):243-50. PubMed ID: 23748241
    [TBL] [Abstract][Full Text] [Related]  

  • 80.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.